Xtx Topco LTD Immunovant, Inc. Transaction History

Xtx Topco LTD

  • $1.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$30.27 - $43.79 $279,603 - $404,488
9,237 New
9,237 $298,000
Q1 2023

May 12, 2023
BUY
$15.27 - $19.72 $313,767 - $405,206
20,548 New
20,548 $318,000
Q4 2021

Feb 11, 2022
SELL
$7.33 - $9.32 $113,013 - $143,695
-15,418 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$7.01 - $11.37 $108,080 - $175,302
15,418 New
15,418 $134,000

Others Institutions Holding IMVT

# of Institutions
212
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email